We are live on
!
Find out more
HWM
HighMark Wealth Management Portfolio holdings
AUM
$246M
1-Year Est. Return
35.95%
This Fund
S&P 500
This Quarter
Est. Return
-4.21%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$121M
AUM Growth
-$12.5M
(-9.4%)
Cap. Flow
-$6.4M
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
74.38%
Holding
590
New
27
Increased
162
Reduced
81
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Protolabs
PRLB
|
+$145K |
| 2 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
+$111K |
| 3 |
AtriCure
ATRC
|
+$87.8K |
| 4 |
Tandem Diabetes Care
TNDM
|
+$78.8K |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$67.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$2.16M |
| 2 |
Krystal Biotech
KRYS
|
+$2.02M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$637K |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$584K |
| 5 |
Halozyme
HALO
|
+$430K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.9% |
| 2 | Financials | 4.48% |
| 3 | Technology | 3.39% |
| 4 | Consumer Discretionary | 2.75% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Zoom
ZM
$26.7B
| $68K | 0.06% |
972
+500
| +106% | +$34.7K |
|
102
iShares Biotechnology ETF
IBB
$9.44B
| $66.9K | 0.06% |
547
| – | – |
|
103
Comcast
CMCSA
$80.9B
| $66.8K | 0.06% |
1,506
+5
| +0.3% | +$223 |
|
104
Advanced Micro Devices
AMD
$807B
| $64K | 0.05% |
622
| – | – |
|
105
Pfizer
PFE
$141B
| $59.9K | 0.05% |
1,805
+18
| +1% | +$637 |
|
106
Huntington Bancshares
HBAN
$34.7B
| $58.8K | 0.05% |
5,657
+80
| +1% | +$898 |
|
|
MRSH
107
Marsh
MRSH
$87.5B
| $58.5K | 0.05% |
308
| – | – |
|
108
Schwab US Large-Cap Growth ETF
SCHG
$58.8B
| $57.6K | 0.05% |
3,168
+1,360
| +75% | +$25.6K |
|
109
DraftKings
DKNG
$12B
| $55.1K | 0.05% |
1,873
+50
| +3% | +$1.48K |
|
110
General Mills
GIS
$19.5B
| $53.7K | 0.04% |
840
+7
| +0.8% | +$495 |
|
111
Coca-Cola
KO
$362B
| $53.4K | 0.04% |
955
+38
| +4% | +$2.28K |
|
112
Marriott International
MAR
$101B
| $49.8K | 0.04% |
253
| – | – |
|
113
ProShares Short S&P500
SH
$916M
| $49.4K | 0.04% |
854
+9
| +1% | +$502 |
|
114
Paycom
PAYC
$7.05B
| $48.5K | 0.04% |
187
-12
| -6% | -$3.66K |
|
115
Five Below
FIVE
$11.5B
| $47.5K | 0.04% |
295
| – | – |
|
116
iShares MSCI EAFE Growth ETF
EFG
$16.4B
| $46.8K | 0.04% |
542
-1
| -0.2% | -$92 |
|
117
Thermo Fisher Scientific
TMO
$208B
| $46.7K | 0.04% |
92
+5
| +6% | +$2.66K |
|
118
Invesco Oil & Gas Services ETF
PXJ
$65M
| $46.7K | 0.04% |
1,514
+4
| +0.3% | +$117 |
|
119
iShares US Healthcare Providers ETF
IHF
$1.21B
| $46.6K | 0.04% |
945
| – | – |
|
120
Airbnb
ABNB
$87.2B
| $46.5K | 0.04% |
339
+330
| +3,667% | +$45.6K |
|
121
Target
TGT
$63.7B
| $46.1K | 0.04% |
417
+68
| +19% | +$8.63K |
|
122
Broadridge
BR
$17.7B
| $45K | 0.04% |
251
+1
| +0.4% | +$177 |
|
123
Reinsurance Group of America
RGA
$15.7B
| $44.9K | 0.04% |
309
-2
| -0.6% | -$283 |
|
124
VanEck Oil Services ETF
OIH
$2.06B
| $43.1K | 0.04% |
125
| – | – |
|
125
Verisk Analytics
VRSK
$27.1B
| $43K | 0.04% |
182
| – | – |
|
Similar funds
PPA
IRP
EPIM
MAMHA
RPCONE
CSC
NTCM
VPA
HighMark Wealth Management's Q3 2023 Portfolio in Review
As of Q3 2023, HighMark Wealth Management held 590 positions worth $121M, down 9.4% from $133M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
HighMark Wealth Management withdrew a net $6.4M in Q3 2023, closing 24 positions and reducing 81 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $2.16M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.9% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
Against the trend, HighMark Wealth Management opened a new position in Insulet worth $19.9K.
- HighMark Wealth Management's largest Q3 2023 buy was Insulet: 125 shares worth $19.9K.
- HighMark Wealth Management added most to Protolabs in Q3 2023, an estimated $145K increase.
- HighMark Wealth Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $637K.
- HighMark Wealth Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $2.16M.
- HighMark Wealth Management's ten largest holdings make up 74% of its $121M portfolio in Q3 2023.
- HighMark Wealth Management opened 27 new positions and closed 24 in Q3 2023.
- HighMark Wealth Management's portfolio value fell 9.4% quarter-over-quarter to $121M.
Based on HighMark Wealth Management's 13F filing for Q3 2023, filed 18 Oct 2023.